Top headlines: Sebi scans Ant group, Novavax vaccine may come to India

Business Standard brings you the top headlines of the day

Novavax vaccineNovavax vaccine
Photo: Shutterstock
BS Web team New Delhi
2 min read Last Updated : Aug 11 2021 | 7:45 AM IST
Covid vaccine from US major Novavax may get approval in India for emergency use. The Reserve Bank of India asks banks and ATM operators to monitor the availability of cash in machines. 

Here are the top headlines of the day:
 
Covid-19 pandemic: Novavax shot may get nod in India even before US

Covid vaccine from US major Novavax may get a nod from the Indian drug regulator even before the vaccine is approved in the US.

The company and its partner Serum Institute of India (SII) have, on August 5, applied for an emergency use authorisation with the Drugs Controller General of India (DCGI) and regulatory bodies in Indonesia and the Philippines. Read more...


Raining IPOs: Industry participants say new filings could cross 100 in 2021

So far this year, 58 companies have filed their draft red herring prospectus (DRHP) with the market regulator for initial public offerings (IPOs), exceeding the combined tally of 50 in the last two years. Industry participants said the filing count could cross 100 this year, setting a new benchmark in terms of amount mobilised in a calendar year. Read more...

Home truth: NCR's unsold inventory dips 26% since RERA, shows data

The vast residential real estate market in the National Capital Region (NCR) — second largest in the country — has undergone massive trans­formation since the introduction of the Real Estate (Regulation and Development) Act, 2016. Read more...

Sebi examines Ant Group and Alibaba holdings in IPO-bound Paytm

Capital markets regulator Securities and Exchange Board of India (Sebi) is examining if Paytm shareholders Ant group and Alibaba—Hangzhou-headquartered Chinese conglomerates--are in compliance with listing regulations. Ahead of Paytm’s public debut, Sebi is looking at whether the two investors must be treated as separate companies or a combined entity. Read more...


Starting October 1, RBI to levy penalty on ATMs that run out of cash

The Reserve Bank of India (RBI) has asked banks and white label automated teller machine (ATM) operators to put in place a robust system that will allow them to monitor the availability of cash in ATMs and ensure timely replenishment to avoid cash-out situations. Read more...

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusClimate ChangeCoronavirus VaccineRBIATM Withdrawalinitial public offerings IPOs

Next Story